Mirum Pharmaceuticals Inc (MIRM)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Travere Therapeutics Provides Corporate Update and 2026 Outlook
Amneal Pharmaceuticals, Inc. - Amneal Unveils Bold New Brand to Reimagine What’s Possible in Making Medicine Accessible for All
Summit Plc - Statement of changes in beneficial ownership of securities
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026
Thermo Fisher Scientific - Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance
Charles River Laboratories Provides Business Updates
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
Thermo Fisher Scientific Announces Strategic Collaboration With NVIDIA Leveraging AI to Advance Scientific Instrumentation and Accelerate Laboratory Performance